Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001079973-23-001646
Filing Date
2023-11-22
Accepted
2023-11-22 16:12:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A schornstein_13da.htm SC 13D/A 47026
  Complete submission text file 0001079973-23-001646.txt   48421
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Subject) CIK: 0001426800 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85836 | Film No.: 231433548
SIC: 2834 Pharmaceutical Preparations

Mailing Address KAISER-FRIEDRICH-ALLEE 2 AACHEN 2M 52074
Business Address
Schornstein Alexander (Filed by) CIK: 0001999256 (see all company filings)

Type: SC 13D/A